@MariaJonsson1 > Man jämför en ny behandling ovanpå standardbehandlingen. Det är nog knappast ett pseudomått. https://t.co/nRxY0abuvX
RT @ChrisW_PharmaG: Another study shows that industry funding is not associated with trial outcome. A favourable primary outcome was seen i…
RT @ChrisW_PharmaG: Another study shows that industry funding is not associated with trial outcome. A favourable primary outcome was seen i…
Another study shows that industry funding is not associated with trial outcome. A favourable primary outcome was seen in 41% of industry trials vs 44% of non-industry trials published in 7 general and 10 speciality medical journals. #pubplan #alltrials htt
@VPplenarysesh "Primary outcomes were surrogate in 223/360 (62%) trials" https://t.co/S0BPpjxfIp
RT @ChrisW_PharmaG: In a study of 360 RCTs published in 17 leading journals "the results for the primary outcome (benefit, neutral or harm)…
In a study of 360 RCTs published in 17 leading journals "the results for the primary outcome (benefit, neutral or harm) were similar in trials funded by industry or non-industry sources". https://t.co/PFE0snywSA @bengoldacre @alltrials @TranspariMED @GoodP
In a study of 360 randomised clinical trials published in 17 leading journals "we found that the results for the primary outcome (benefit, neutral or harm) were similar in trials funded by industry or non-industry sources". https://t.co/PFE0snywSA #alltria
Outcomes, Interventions & Funding in Randomised Research Published in High-Impact Journals https://t.co/UuymFEuFdH